Podcast: Switching Suppressed Patients
Audio on Optimizing Switch Strategies for Patients With Viral Suppression

Released: June 10, 2021

Expiration: June 09, 2022

Daniel R. Kuritzkes
Daniel R. Kuritzkes, 医学博士
Chloe Orkin
Chloe Orkin, MBChB, FRCP, MD

Activity

Progress
1
Course Completed

In this episode, the first in a yearlong series on Key Decisions in HIV Care, Daniel R. Kuritzkes, MD, and Chloe Orkin, MBChB, FRCP, MD, discuss important considerations when switching ART in patients with viral suppression on their current regimen, including guideline recommendations and data supporting different switch regimen options such as single-tablet triple therapy, 2-drug oral regimens, doravirine-based regimens, and long-acting injectable therapy. Following their dialogue, the faculty field questions from healthcare professionals.

Presenters:

Daniel R. Kuritzkes, MD
Chief, Division of Infectious  
Diseases
Brigham and Womens Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Chloe Orkin, MBChB, FRCP, MD
Professor of HIV  
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom